GleamWall
中文EN

EW Edwards Lifesciences Corp

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1099800 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.4%
TTM net income YoY-25.3%
TTM EPS YoY-23.7%
Revenue 3-yr CAGR9.4%
Net income 3-yr CAGR-10.6%

Margins

Gross margin78.0%
Operating margin21.6%
Net margin15.3%
FCF margin21.3%
EBITDA margin24.2%

Returns

ROE9.7%
ROA7.5%
ROIC (approx.)12.1%
Asset turnover0.49x

Leverage & solvency

Liabilities / assets22.5%
Debt / equity0.06x
Current ratio4.60x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.68x
Accruals ratio-5.1%
Payout ratio—
Capex / revenue4.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$6.07B$5.44B
Cost of revenue$1.33B$1.12B
Gross profit$4.73B$4.32B
R&D expense$1.08B$1.05B
SG&A expense$2.09B$1.79B
Operating income$1.26B$1.38B
Interest expense$20.40M$19.80M
Pretax income$1.27B$1.55B
Income tax$216.90M$152.10M
Net income$1.07B$4.17B
EBITDA$1.42B$1.53B
EPS (basic)1.846.98
EPS (diluted)1.836.97
Weighted avg. shares (diluted)585.80M599.30M
Banking
Net interest income-$20.40M-$19.80M
Balance sheet
Cash & equivalents$2.94B$3.06B
Short-term investments$1.29B$930.70M
Receivables$659.60M$609.10M
Inventory$1.13B$1.09B
Current assets$6.74B$6.29B
PP&E, net$1.81B$1.69B
Goodwill$1.77B$1.78B
Intangibles$1.13B$1.18B
Total assets$13.70B$13.06B
Current liabilities$1.81B$1.51B
Long-term debt$598.30M$597.70M
Total debt$598.30M$597.70M
Total liabilities$3.36B$2.99B
Shareholders' equity$10.34B$10.00B
Net debt-$2.34B-$2.46B
Shares outstanding580.70M588.60M
Cash flow statement
Operating cash flow$1.60B$542.30M
Capital expenditure$260.20M$252.40M
Free cash flow$1.33B$289.90M
Investing cash flow-$712.90M$2.31B
Financing cash flow-$956.80M-$983.00M
Depreciation & amortization$156.60M$155.20M
Stock-based compensation$158.10M$162.30M
Share buybacks$893.40M$1.16B

Free plan shows the latest 2 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.